NCT07573930 Metabolic Control in Anesthesia and Surgery
| NCT ID | NCT07573930 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zealand University Hospital |
| Condition | Anesthesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-04-23 |
| Primary Completion | 2028-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2026-04-23 with a primary completion date of 2028-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to investigate how a standard dose of the drug dexamethasone affects blood sugar levels during and after non-cardiac surgery in adult patients. The main questions it aims to answer are: * How does dexamethasone influence blood sugar levels in patients undergoing non-cardiac surgery? * Does continuous glucose monitoring (CGM) provide a more accurate estimate of blood sugar fluctuations compared to traditional time-specific finger-prick measurements? Participants are scheduled to receive dexamethasone as part of standard anesthesia care and will undergo their planned surgery. As part of the study, a continuous glucose monitoring (CGM) device will be placed on their upper arm approximately 12 hours before surgery and will remain in place for up to 10 days after the operation. During this period, their blood sugar levels will be measured using both the CGM device and traditional finger-prick tests. CGM readings are blinded for both participants and clinicians. No additional treatments or changes to their standard care will be made as a result of their participation in the study. The study will include 100 adult patients from the Department of Anesthesiology at Sjællands University Hospital, Roskilde.
Eligibility Criteria
Inclusion Criteria: * Adult patients (≥18 years) scheduled for elective non cardiac surgery * Expected surgery duration \>1 hour * Administration of dexamethasone as part of standard anaesthetic regimen or planned by the responsible anaesthetist to enhance recovery or to limit risk of PONV. * Ability to provide written informed consent Exclusion Criteria: * Not possible to obtain consent or permission * Known allergy or adverse reaction to dexamethasone * Type 1 diabetes (due to need for insulin titration) * Active infection, sepsis, or immunosuppression * Contraindications to continuous glucose monitoring (CGM)
Contact & Investigator
Anne M Brinck, Msc Medicine
PRINCIPAL INVESTIGATOR
Zealand University Hospital, Roskilde, Denmark
Frequently Asked Questions
Who can join the NCT07573930 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07573930 currently recruiting?
Yes, NCT07573930 is actively recruiting participants. Contact the research team at abrinc@regionsjaelland.dk for enrollment information.
Where is the NCT07573930 trial being conducted?
This trial is being conducted at Roskilde, Denmark.
Who is sponsoring the NCT07573930 clinical trial?
NCT07573930 is sponsored by Zealand University Hospital. The principal investigator is Anne M Brinck, Msc Medicine at Zealand University Hospital, Roskilde, Denmark. The trial plans to enroll 100 participants.